Jacobs & CO Johnson & Johnson Transaction History

Jacobs & CO

$1 Billion
Q3 2024

A detailed history of Jacobs & CO transactions in Johnson & Johnson stock. As of the latest transaction made, Jacobs & CO holds 56,390 shares of JNJ stock, worth $8.77 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares

56,390

Previous 57,274 1.54%

Holding current value

$8.77 Million

Previous $8.37 Million 9.16%

% of portfolio

0.91%

Previous 0.88%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 01, 2024	SELL	$145.48 - $167.38 $128,604 - $147,963	-884 Reduced 1.54%	56,390 $9.14 Million
Q2 2024 Jul 12, 2024	BUY	$144.38 - $157.78 $201,410 - $220,103	1,395 Added 2.5%	57,274 $8.37 Million
Q1 2024 Apr 12, 2024	BUY	$155.22 - $162.74 $157,858 - $165,506	1,017 Added 1.85%	55,879 $8.84 Million
Q4 2023 Jan 17, 2024	BUY	$145.6 - $158.88 $280,134 - $305,685	1,924 Added 3.63%	54,862 $8.6 Million
Q3 2023 Oct 13, 2023	SELL	$155.75 - $174.48 $1.41 Million - $1.58 Million	-9,059 Reduced 14.61%	52,938 $8.25 Million
Q2 2023 Jul 11, 2023	BUY	$154.35 - $166.11 $47,539 - $51,161	308 Added 0.5%	61,997 $10.3 Million
Q1 2023 Apr 17, 2023	BUY	$151.05 - $180.26 $268,113 - $319,961	1,775 Added 2.96%	61,689 $9.56 Million
Q4 2022 Jan 13, 2023	BUY	$160.2 - $179.79 $325,366 - $365,153	2,031 Added 3.51%	59,914 $10.6 Million
Q3 2022 Oct 11, 2022	SELL	$161.33 - $179.52 $120,190 - $133,742	-745 Reduced 1.27%	57,883 $9.46 Million
Q2 2022 Jul 19, 2022	SELL	$168.19 - $186.01 $490,946 - $542,963	-2,919 Reduced 4.74%	58,628 $10.4 Million
Q1 2022 Apr 14, 2022	SELL	$158.14 - $179.59 $159,563 - $181,206	-1,009 Reduced 1.61%	61,547 $10.9 Million
Q4 2021 Jan 21, 2022	BUY	$155.93 - $173.01 $605,632 - $671,970	3,884 Added 6.62%	62,556 $10.7 Million
Q3 2021 Oct 13, 2021	BUY	$161.5 - $179.47 $20,187 - $22,433	125 Added 0.21%	58,672 $9.48 Million
Q2 2021 Jul 15, 2021	SELL	$159.48 - $171.07 $258,198 - $276,962	-1,619 Reduced 2.69%	58,547 $9.65 Million
Q1 2021 Apr 05, 2021	BUY	$153.07 - $170.48 $87,402 - $97,344	571 Added 0.96%	60,166 $9.89 Million
Q4 2020 Jan 12, 2021	SELL	$137.11 - $157.38 $200,591 - $230,246	-1,463 Reduced 2.4%	59,595 $9.38 Million
Q3 2020 Dec 03, 2020	SELL	$140.38 - $153.83 $43,237 - $47,379	-308 Reduced 0.5%	61,058 $9.09 Million
Q2 2020 Jul 09, 2020	SELL	$128.81 - $155.51 $96,221 - $116,165	-747 Reduced 1.2%	61,366 $8.63 Million
Q1 2020 Apr 13, 2020	SELL	$111.14 - $153.99 $10,224 - $14,167	-92 Reduced 0.15%	62,113 $8.15 Million
Q4 2019 Jan 29, 2020	BUY	$127.5 - $146.44 $344,632 - $395,827	2,703 Added 4.54%	62,205 $9.07 Million
Q3 2019 Nov 04, 2019	SELL	$126.95 - $142.14 $136,852 - $153,226	-1,078 Reduced 1.78%	59,502 $7.7 Million
Q2 2019 Aug 01, 2019	BUY	$131.15 - $144.24 $4,327 - $4,759	33 Added 0.05%	60,580 $8.44 Million
Q1 2019 Apr 29, 2019	BUY	$125.72 - $139.79 $244,776 - $272,171	1,947 Added 3.32%	60,547 $8.46 Million
Q4 2018 Feb 07, 2019	BUY	$122.84 - $147.84 $309,925 - $373,000	2,523 Added 4.5%	58,600 $7.56 Million
Q3 2018 Oct 23, 2018	SELL	$121.58 - $142.88 $240,606 - $282,759	-1,979 Reduced 3.41%	56,077 $7.75 Million
Q2 2018 Jul 19, 2018	SELL	$119.4 - $131.76 $74,863 - $82,613	-627 Reduced 1.07%	58,056 $7.04 Million
Q1 2018 Apr 30, 2018	BUY	$125.1 - $148.14 $7.03 Million - $8.32 Million	56,182 Added 2246.38%	58,683 $7.52 Million
Q4 2017 Feb 09, 2018	SELL	$131.22 - $143.62 $41,990 - $45,958	-320 Reduced 11.34%	2,501 $267,000
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $365,234 - $381,906	2,821	2,821 $269,000

Others Institutions Holding JNJ

# of Institutions

4,227

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs & CO with notifications on news.

Account